HFM
INO icon

Hartford Financial Management’s Inovio Pharmaceuticals INO Stock Holding History

Hartford Financial Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-48
Closed -$3K – 363
2017
Q3 		$3K Buy
48
+23
+92% +$1.71K ﹤0.01% 345
2017
Q2 		$2K Hold
25
– – ﹤0.01% 342
2017
Q1 		$1K Hold
25
– – ﹤0.01% 337
2016
Q4 		$2K Hold
25
– – ﹤0.01% 297
2016
Q3 		$2K Hold
25
– – ﹤0.01% 298
2016
Q2 		$2K Hold
25
– – ﹤0.01% 279
2016
Q1 		$2K Hold
25
– – ﹤0.01% 282
2015
Q4 		$2K Hold
25
– – ﹤0.01% 264
2015
Q3 		$1K Hold
25
– – ﹤0.01% 252
2015
Q2 		$2K Buy
+25
New +$2.67K ﹤0.01% 263

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hartford Financial Management's INO Position: Q4 2017 in Review

Hartford Financial Management sold out of Inovio Pharmaceuticals (INO) in Q4 2017, closing a stake of 48 shares — an estimated $3K sold.

Hartford Financial Management first reported a position in INO in Q2 2015 and held it in 10 quarters. The position peaked at $3K in Q3 2017. 133 funds tracked by Wall St. Rank hold INO as of Q4 2017.

  • Hartford Financial Management reported no remaining Inovio Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Hartford Financial Management sold 48 Inovio Pharmaceuticals shares in Q4 2017, an estimated $3K.
  • Hartford Financial Management first reported a position in Inovio Pharmaceuticals in Q2 2015 and held it in 10 quarters.
  • Hartford Financial Management's Inovio Pharmaceuticals position peaked at $3K in Q3 2017.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2017.

Based on Hartford Financial Management's 13F filing for Q4 2017, filed 16 Jan 2018.